Graff Fred 4
4 · Recro Pharma, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
Graff Fred
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-09-28+2,000→ 10,000 total
Footnotes (1)
- [F1]On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,000 performance-based restricted stock units, which were converted into 2,000 shares of common stock on a one-for-one basis.